For the week of May 20 – Stock mentions: Alibaba, JD, Eli Lilly, 3M, Nvidia, Xilinx
Here are a few more stock predictions for the week of May 20, 2019.
The Chinese yuan will continue to devalue against the US dollar and back to 7.
Yuan Vs. Dollar
The weaker yuan will sink China-based ADR’s Alibaba and JD.com. The chart below shows the US dollar to yuan in an inverse chart to the one above. One can quickly see how when the yuan was strengthening versus the dollar; the stock prices were able to rise. However, when the currency was weakening, the stocks were falling.
Alibaba (BABA)
I think Alibaba continues to decline this week, dropping below $166.60, and heads towards $150.
JD.com (JD)
JD.com has been unable to rise above resistance at $30 and is likely heading back to $27.50.
3M (MMM)
3M has fallen to its lowest levels since 2016 and looks like it may fall even further to perhaps $164.
Eli Lilly (LLY)
Eli Lilly may be in danger of falling further this week, with the potential to be on its way towards $104.
Unlock Deeper Insights with Exclusive Member-Only Video Content on The Market Chronicles YouTube Channel – Just $34.99/Month
Systematic Selling May Soon Return
Rates Look Through Headline Job Report
October Job Report Replay
Nvidia (NVDA)
Nvidia is likely to continue to decline this week too, heading towards $150. (premium video content: AMD And Nvidia 2 Opposing Points Of View)
Xilinx (XLNX)
Xilinx may be looking to fill the gap around $92.
That is it for the weekend, see you Monday.Mike
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.